Effects of Nicotinamide in the Protection of Apoptosis and Necrosis in a Stroke

Publish Year: 1398
نوع سند: مقاله کنفرانسی
زبان: English
View: 335

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

NIMED03_137

تاریخ نمایه سازی: 7 آبان 1398

Abstract:

Nicotinamide is a form of vitamin B3 which is thought to have a potential role in the treatment of Alzheimer’s disease. This substance may have neuroprotective properties, which may protect brain against damage in ischemia-reperfusion. However, the dosage of therapy is not truly clarifying. Materials and Methods: Transient focal cerebral ischemia was persuaded by middle cerebral artery obstruction for 70min. Several doses of nicotinamide were administered upon reperfusion. Neurological detection scores and infarct volumes were recorded. Results: The scores of neurological deficiency and volumes of infarction were significantly decreased by nicotinamide therapy.Nicotinamide administrated during the first 4 h of reperfusion can suppress the progress of brain damage. Conclusions: Poly ADP-ribose polymerase (PARP) has a potential effect in repairing the DNA in stroke. Nicotinamide provides energy as a suppressor of PARP.The results propose that initial use of nicotinamide at an appropriate dosage meaningfully improves apoptotic and necrotic brain damage after focal ischemia–reperfusion.

Authors

Neshat Ebrahimi

Laboratory of Cedars-Sinai Medical Center, Los Angles, California, USA

Zahra Farjami

Department of Modern Sciences and Technologies; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Negar Khodaeinia

National Research Center of Genetic Engineering and Biotechnology (NIGEB), Department of Medical Genetics, Tehran, Iran

Amirhossein Ashnaei

Department of Modern Sciences and Technologies; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran